Granite Bay Wealth Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Granite Bay Wealth Management’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-22,520	Closed	-$8K	–	80
2023 Q1	$8K	Buy	22,520 +3,400	+18%	+$3.05K	0.01%	75
2022 Q4	$17K	Sell	19,120 -700	-4%	-$929	0.01%	66
2022 Q3	$31K	Hold	19,820	–	–	0.02%	57
2022 Q2	$40K	Sell	19,820 -300	-1%	-$519	0.03%	56
2022 Q1	$47K	Buy	20,120 +3,850	+24%	+$12K	0.04%	61
2021 Q4	$76K	Buy	+16,270	New	+$101K	0.08%	60

Other funds holding SRNE

SlateStone Wealth Jupiter, Florida $1.31B AUM 26.51% 1-Year Est. Return

KLCM Advisors Milwaukee, Wisconsin $1.27B AUM 31.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

OAJ

Ogorek Anthony Joseph Williamsville, New York $403M AUM 22.57% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

TCOV

Trust Company of Vermont Brattleboro, Vermont $2.68B AUM

CFGS

Concourse Financial Group Securities Birmingham, Alabama $1.77B AUM 17.37% 1-Year Est. Return

Granite Bay Wealth Management's SRNE Position: Q2 2023 in Review

Granite Bay Wealth Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2023, closing a stake of 22,520 shares — an estimated $8K sold.

Granite Bay Wealth Management first reported a position in SRNE in Q4 2021 and held it in 6 quarters. The position peaked at $76K in Q4 2021. 9 funds tracked by Wall St. Rank hold SRNE as of Q2 2023.

Granite Bay Wealth Management reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2023 after selling out during the quarter.
Granite Bay Wealth Management sold 22,520 Sorrento Therapeutics, Inc. shares in Q2 2023, an estimated $8K.
Granite Bay Wealth Management first reported a position in Sorrento Therapeutics, Inc. in Q4 2021 and held it in 6 quarters.
Granite Bay Wealth Management's Sorrento Therapeutics, Inc. position peaked at $76K in Q4 2021.
9 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2023.

Based on Granite Bay Wealth Management's 13F filing for Q2 2023, filed 19 Jul 2023.